Lung Cancer | Establishment of a PDT Patient Registry
Lung Cancer research study
What is the primary objective of this study?
This is a non-intervention patient registry to gather data on the use of photodynamic therapy under real-life conditions. It will involve up to 20 sites in USA.
Who is eligible to participate?
Inclusion Criteria: - All adult patients (≥ 18 years of age) treated with PDT. - Women and men and members of all races and ethnic groups. - Subjects may have received prior treatment for their cancer. - Subjects to give a written informed consent for prospectively collected data. Exclusion Criteria: - Subjects participating in any interventional studies.
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Other:No interventionThere are no interventions associated with this registry as it is purely observational.
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Not yet recruiting
Start Date: July 15, 2018
Completed Date: December 15, 2023
Type: Observational [Patient Registry]
Primary Outcome: PDT Outcome
Study sponsors, principal investigator, and references
Principal Investigator: Sandra Gollnick, Ph.D.
Lead Sponsor: Concordia Laboratories Inc.
Collaborator: Roswell Park Cancer Institute